The Recall Desk
HighFDA (Devices)·Z-0846-2014·Announced 2014-02-05

Focus Diagnostics Recalls Simplexa Flu A/B & RSV Direct Assay Kits

Focus Diagnostics is recalling 1,052 Simplexa Flu A/B & RSV Direct assay kits due to sporadic false positive RSV signals that may lead to incorrect diagnostic results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk of harm (incorrect diagnosis) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Focus Diagnostics Inc is initiating an urgent safety notice correction for the Simplexa Flu A/B & RSV Direct assay, Model MOL2650. The recall involves 1,052 kits with lot numbers 24493, 24495, 24535, and 24536. This in vitro diagnostic test is intended for use on the 3M Integrated Cycler instrument to detect and differentiate influenza A, influenza B, and respiratory syncytial virus (RSV) RNA in human nasopharyngeal swabs.

The recall was initiated because Focus Diagnostics received customer complaints regarding sporadic false positive RSV signals in the affected lots. These false positives may result in a higher RSV false positive rate, potentially leading to incorrect diagnostic conclusions for patients with respiratory tract infections.

The affected products were distributed nationwide in the United States, including states such as NY, MA, NJ, OH, CA, HI, CO, MN, FL, PA, IA, WI, AZ, TX, TN, IL, SD, MO, NM, AR, and WV. The kits were also distributed internationally to Sweden, Israel, Canada, and Slovenia. Healthcare facilities and laboratories should stop using the affected lots and contact Focus Diagnostics for further instructions.

The recalled product

Product
Simplexa Flu A/B & RSV Direct assay, Model MOL2650. The Focus Diagnostics Simplexa Flu A/B & RSV Direct assay is intended for use on the 3M Integrated Cycler instrument for the in vitro qualitative detection and differentiation of influenza A virus, influenza B virus, and resp
Affected units
1,052

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Model Number MOL2650 Lot Numbers: 24493
  • 24495
  • 24535
  • 24536.

Distribution

Distributed nationwide across the United States.

The notice also names 22 states specifically: